TriSalus Life Sciences (TLSI) Interest Expenses (2022 - 2026)

TriSalus Life Sciences has reported Interest Expenses for 5 years, with the latest figure at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Interest Expenses rose 18.78% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (up 34.33% YoY), and the FY2025 full-year result was $5.5 million, up 79.42% from the prior year.
• Interest Expenses for Q1 2026 stood at $1.4 million, down from $1.5 million in the prior quarter.
• The five-year high for Interest Expenses was $1.5 million in Q3 2025, with the low at $1000.0 in Q4 2022.
• Historically, Interest Expenses has averaged $720500.0 across 5 years, with a median of $972500.0 in 2024.
• Annual changes were most pronounced in 2024 — Interest Expenses plunged 40.0% — and 2025, when it surged 40200.0%.
• TriSalus Life Sciences' Interest Expenses stood at $1000.0 in 2022, then surged by 200.0% to $3000.0 in 2023, then surged by 35500.0% to $1.1 million in 2024, then soared by 35.96% to $1.5 million in 2025, then declined by 1.1% to $1.4 million in 2026.
• The last three Interest Expenses figures came in at $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.